Evaluation of prostate-specific antigen (PSA) and characterization of histological material after TRUS biopsy or surgery have been set as a gold standard for PCa diagnosis, though the diagnostic value of these methods is hotly debated in the literature due to high incidence of false-positive and false-negative results [2,3,23,24]. This evidence concerns the gene KLK3 and posterior cortical atrophy.